Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

A new score can help predict which patients might have trouble urinating after prostate surgery.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

Dutasteride is more effective than finasteride in reducing urinary retention and surgery risks in people aged 65 and older.

Older men with postoperative urinary retention are more likely to need future bladder procedures.

Unexplained anemia in older men may be linked to urological issues like urinary retention.

Early intervention for acute urinary retention can reduce costs and improve care.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Older adults using diuretics should manage water intake carefully to avoid low sodium levels.

Older adults on certain medications should be carefully monitored for urinary issues and low sodium levels.

Dual therapy with specific medications can help manage male urinary symptoms and reduce side effects.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

COVID-19 worsens urinary symptoms in men with benign prostatic hyperplasia, requiring careful treatment management.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

Evidence-based urology improved treatment and quality of life for conditions like BPH by shifting from surgery to effective medications like finasteride and dutasteride.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Men over 50 often experience urinary issues due to prostate enlargement or bladder problems, treatable with therapies, medications, or surgery.

Finasteride improves urinary symptoms and quality of life in BPH patients, especially with larger prostate size.

Tamsulosin works faster, but both drugs have similar effects after 6 months.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Finasteride effectively reduces the need for surgery and urinary issues in men with BPH over the long term.

Finasteride is a cost-effective option for treating BPH, reducing risk of urinary issues and surgery.

Finasteride effectively treats benign prostatic hyperplasia by reducing prostate size and improving urinary symptoms.

Taking 5-ARI before prostate laser surgery may lead to more blood changes, longer surgery, and more urinary issues.